… of stroke. The use of agents from these classes—also known as non-vitamin K antagonist
oral anticoagulants (… The rapid onset and relatively short half-life of anticoagulant action offers …

… Point of action of novel oral anticoagulants in the coagulation cascade. … This review focuses
on the most recent trials investigating these substances for stroke prevention in AF and for …

… as good as warfarin for stroke prevention in atrial fibrillation and … they are recommended for
stroke prevention in atrial fibrillation. … the role of anticoagulation for stroke prevention in atrial …

Background— The risk of further intracranial hemorrhage (ICH) and the benefit of stroke risk
reduction with the use of oral anticoagulants for patients who have atrial fibrillation with a …

… Our analysis also shows that the novel oral anticoagulants as a whole provide additional …
prevention. However, well controlled, adjusted dose warfarin is associated with less stroke and …

AF is the most common sustained arrhythmia and the leading cause of stroke in adults
worldwide. 1, 2 Traditionally, warfarin and other VKAs have been the mainstay treatment option …

… Oral direct factor Xa inhibitors and oral direct thrombin inhibitors are new oral anticoagulants
(NOACs) for stroke prevention in atrial fibrillation (AF). We systematically reviewed their risk …

… for acute venous thromboembolism or stroke prevention in atrial fibrillation. Nineteen … oral
anticoagulant treatment option available for patients. However, 4 direct oral anticoagulants …

… To our knowledge, this is the first study of all currently licensed direct acting oral anticoagulants
(DOACs) for stroke prevention in patients with atrial fibrillation that has provided a rank …

… centers have an important impact of the implementation of OAT for secondary stroke prevention.
… oral anticoagulation for secondary stroke prevention than toward regional differences. …